Other study has shown that increased IGFBP7 also may remodel the tumor microenvironment and promote the progression of esophageal squamous cell carcinoma by activating the transforming growth factor-β1/SMAD signaling pathway (Li et al., 2022). This evidence concerns the gene IGFBP7 and esophageal squamous cell carcinoma.